To begin addressing this hypothesis, we compared PARP-1 expression in postmortem hippocampal brain tissue derived from patients with neuropathologically confirmed AD to control hippocampal brain tissue from patients without significant neuropathology. The gene discussed is PARP1; the disease is Alzheimer disease.